441 related articles for article (PubMed ID: 12504935)
21. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia.
Armstrong RA; Reynolds RM; Leask R; Shearing CH; Calder AA; Riley SC
Prenat Diagn; 2009 Oct; 29(10):982-5. PubMed ID: 19582702
[TBL] [Abstract][Full Text] [Related]
22. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
23. Activin A and inhibin A as possible endocrine markers for pre-eclampsia.
Muttukrishna S; Knight PG; Groome NP; Redman CW; Ledger WL
Lancet; 1997 May; 349(9061):1285-8. PubMed ID: 9142063
[TBL] [Abstract][Full Text] [Related]
24. Placental production and maternal serum and urine levels of inhibin A and activin A are modified by antihypertensive therapy in hypertensive disorders of pregnancy.
Khalil A; Jauniaux E; Harrington K; Muttukrishna S
Clin Endocrinol (Oxf); 2009 Jun; 70(6):924-31. PubMed ID: 18803676
[TBL] [Abstract][Full Text] [Related]
25. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
[TBL] [Abstract][Full Text] [Related]
26. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.
Florio P; Reis FM; Pezzani I; Luisi S; Severi FM; Petraglia F
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):165-9. PubMed ID: 12601840
[TBL] [Abstract][Full Text] [Related]
27. [Inhibins and Activin A in hypertensive Disorders of Pregnancy and HELLP-Syndrome].
Seufert R; Neubert S; Tanner B; Schaffrath M; Pollow K; Kölbl H
Zentralbl Gynakol; 2004 Jun; 126(3):148-53. PubMed ID: 15236099
[TBL] [Abstract][Full Text] [Related]
28. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Lambert-Messerlian GM; Silver HM; Petraglia F; Luisi S; Pezzani I; Maybruck WM; Hogge WA; Hanley-Yanez K; Roberts JM; Neveux LM; Canick JA
J Soc Gynecol Investig; 2000; 7(3):170-4. PubMed ID: 10865185
[TBL] [Abstract][Full Text] [Related]
29. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
Gravett CP; Buckmaster JG; Watson PT; Gravett MG
Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970
[TBL] [Abstract][Full Text] [Related]
30. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
31. Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
Shenhav S; Gemer O; Sassoon E; Volodarsky M; Peled R; Segal S
Prenat Diagn; 2002 Jul; 22(7):579-82. PubMed ID: 12124692
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of activin A and inhibin A are not related to the increased susceptibility to pre-eclampsia in type I diabetic pregnancies.
Ekbom P; Damm P; Andersson AM; Skakkebaek NE; Feldt-Rasmussen U; Mathiesen ER
Acta Obstet Gynecol Scand; 2006; 85(2):143-7. PubMed ID: 16532905
[TBL] [Abstract][Full Text] [Related]
33. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress in midpregnancy as a predictor of gestational hypertension and pre-eclampsia.
Rogers MS; Wang CC; Tam WH; Li CY; Chu KO; Chu CY
BJOG; 2006 Sep; 113(9):1053-9. PubMed ID: 16956336
[TBL] [Abstract][Full Text] [Related]
35. Maternal serum activin A and the prediction of intrauterine growth restriction.
Barkehall-Thomas A; Tong S; Baker LS; Edwards A; Wallace EM
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):97-101. PubMed ID: 16638029
[TBL] [Abstract][Full Text] [Related]
36. Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity.
Laivuori H; Kaaja R; Turpeinen U; Stenman UH; Ylikorkala O
Br J Obstet Gynaecol; 1999 Dec; 106(12):1298-303. PubMed ID: 10609725
[TBL] [Abstract][Full Text] [Related]
37. Inhibins and activins in human fetal abnormalities.
Lambert-Messerlian GM; Pinar H; Laprade E; Tantravahi U; Schneyer A; Canick JA
Mol Cell Endocrinol; 2004 Oct; 225(1-2):101-8. PubMed ID: 15451574
[TBL] [Abstract][Full Text] [Related]
38. Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin.
Prakash A; Laird S; Li TC; Ledger WL
Fertil Steril; 2006 Jan; 85(1):165-70. PubMed ID: 16412749
[TBL] [Abstract][Full Text] [Related]
39. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
40. Multiple marker second trimester serum screening for pre-eclampsia.
Wald NJ; Morris JK
J Med Screen; 2001; 8(2):65-8. PubMed ID: 11480445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
